Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Agulnik

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Oral Oncology|December 7, 2007
Nasopharyngeal carcinoma: current management, future directions and dental implicationsMark Agulnik, Joel B Epstein
Cancer|June 7, 2022
Evolving strategies for management of desmoid tumorRichard F Riedel, Mark Agulnik
Drugs|August 7, 2008
Promising newer molecular-targeted therapies in head and neck cancerLili X Wang, Mark Agulnik
Hematology/Oncology Clinics of North America|November 23, 2006
The changing management of low-grade astrocytomas and oligodendrogliomasMark Agulnik, Warren P Mason
Current Neurology and Neuroscience Reports|April 26, 2006
Recent advances in the treatment of oligodendrogliomasMark Agulnik, Warren P Mason
Seminars in Oncology|June 12, 2008
Salivary gland malignancies: the role for chemotherapy and molecular targeted agentsSujani G Surakanti, Mark Agulnik
American Journal of Clinical Oncology|July 10, 2012
Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumorMark Agulnik, Jennifer L Giel
Expert Opinion on Pharmacotherapy|March 1, 2006
Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USAMark Agulnik, Lillian L Siu
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
The role of inhibitors of the epidermal growth factor in management of head and neck cancerBruce Brockstein, Mario Lacouture, Mark Agulnik
Oncology (Williston Park, N.Y.)|December 9, 2010
Head and neck cancer: changing epidemiology and public health implicationsLeslie Kim, Tiffany King, Mark Agulnik
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Oral Oncology|December 7, 2007
Nasopharyngeal carcinoma: current management, future directions and dental implicationsMark Agulnik, Joel B Epstein
Cancer|June 7, 2022
Evolving strategies for management of desmoid tumorRichard F Riedel, Mark Agulnik
Drugs|August 7, 2008
Promising newer molecular-targeted therapies in head and neck cancerLili X Wang, Mark Agulnik
Hematology/Oncology Clinics of North America|November 23, 2006
The changing management of low-grade astrocytomas and oligodendrogliomasMark Agulnik, Warren P Mason
Current Neurology and Neuroscience Reports|April 26, 2006
Recent advances in the treatment of oligodendrogliomasMark Agulnik, Warren P Mason
Seminars in Oncology|June 12, 2008
Salivary gland malignancies: the role for chemotherapy and molecular targeted agentsSujani G Surakanti, Mark Agulnik
American Journal of Clinical Oncology|July 10, 2012
Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumorMark Agulnik, Jennifer L Giel
Expert Opinion on Pharmacotherapy|March 1, 2006
Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USAMark Agulnik, Lillian L Siu
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
The role of inhibitors of the epidermal growth factor in management of head and neck cancerBruce Brockstein, Mario Lacouture, Mark Agulnik
Oncology (Williston Park, N.Y.)|December 9, 2010
Head and neck cancer: changing epidemiology and public health implicationsLeslie Kim, Tiffany King, Mark Agulnik
Pageof 12